BNKL
COM:BIONIKLABS
BIONIK
- Stock
Market Cap
12
Beta: -
Volume Today
1K
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Mar '16 | Mar '17 | Mar '18 | Mar '19 | Mar '20 | Mar '21 | Mar '22 | Mar '23 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
average inventory | 114.12K - | 232.85K 104.03% | 321.56K 38.10% | 732.57K 127.82% | 875.81K 19.55% | 941.59K 7.51% | 1.11M 18.18% | ||||
average payables | 75 - | 8.31K 10,982.67% | 168.67K 1,929.26% | 552.80K 227.73% | 754.70K 36.52% | 936.76K 24.12% | 1.00M 7.07% | 655.95K 34.60% | 379.95K 42.08% | 431.35K 13.53% | |
average receivables | 228.92K - | 441.57K 92.89% | 333.01K 24.59% | 1.57M 371.08% | 1.90M 21.37% | 1.52M 20.07% | 1.20M 20.91% | 363.96K 69.76% | |||
book value per share | -0.02 - | -0.07 301.00% | 0.55 852.64% | 37.90 6,750.76% | 30.40 19.79% | 11.60 61.84% | 2.99 74.23% | 0.64 78.59% | 0.50 21.71% | -0.24 147.44% | |
capex per share | -0.09 - | -0.28 210.63% | -0.03 88.52% | -0.04 34.44% | -0.04 16.81% | -0.00 - | 7.27K 339,856,085.01% | ||||
capex to depreciation | -0.68 - | -0.27 59.86% | -0.05 80.74% | -0.29 459.64% | -0.42 43.49% | -0.12 - | 794.48K 652,256,532.00% | ||||
capex to operating cash flow | 0.01 - | 0.02 170.55% | 0.00 88.55% | 0.01 294.15% | 0.02 59.78% | 0.00 - | -14.82K 491,555,587.55% | ||||
capex to revenue | -0.30 - | -0.02 92.69% | -0.03 43.56% | -0.07 136.45% | -0.01 - | 27.80K 283,275,818.60% | |||||
cash per share | 0.01 - | 0.01 26.68% | 11.28 186,134.24% | 0.89 92.12% | 0.75 15.18% | 0.19 74.91% | 0.51 169.43% | 0.12 76.71% | 0.34 187.26% | 0.06 81.83% | |
days of inventory on hand | 214.30 - | 215.23 0.43% | 90.83 57.80% | 432.86 376.54% | 936.98 116.46% | 1.36K 44.78% | 463.11 65.86% | ||||
days payables outstanding | 859.00 - | 736.77 - | 656.89 10.84% | 257.23 60.84% | 350.18 36.13% | 615.67 75.82% | 347.51 43.56% | 249.63 28.17% | |||
days sales outstanding | 271.42 - | 88.98 67.22% | 325.73 266.06% | 154.47 52.58% | 652.19 322.22% | 78.76 87.92% | 91.61 16.32% | ||||
debt to assets | 0.09 - | 0.00 97.98% | 0.11 - | 0.42 276.95% | 0.72 - | ||||||
debt to equity | 0.11 - | 0.00 97.74% | 0.16 - | 1.13 625.96% | -1.47 - | ||||||
dividend yield | |||||||||||
earnings yield | -0.00 - | -0.00 125.25% | 0.01 8,760.82% | -0.10 822.40% | -2.03 1,836.67% | -1.05 48.12% | -3.02 187.79% | -1.09 64.01% | -7.12 554.21% | -5.01K 70,267.59% | |
enterprise value | 176.61M - | 176.61M 0.00% | 66.18M 62.53% | 39.67M 40.05% | 6.81M 82.82% | 9.60M 40.82% | 8.05M 16.09% | 15.93M 97.84% | 200.13K 98.74% | 4.75M 2,271.71% | |
enterprise value over ebitda | -13.47K - | -5.98K 55.60% | -10.07 99.83% | -5.42 46.22% | -0.71 86.93% | -1.38 95.25% | -0.74 46.39% | -2.64 256.30% | -0.05 98.27% | -0.99 2,076.28% | |
ev to operating cash flow | -12.09K - | -13.38K 10.64% | -13.94 99.90% | -5.67 59.29% | -0.88 84.42% | -1.04 17.61% | -0.89 14.53% | -3.45 287.81% | -0.05 98.60% | -1.40 2,803.82% | |
ev to sales | 33.96K - | 29.44K 13.33% | 69.37 - | 6.90 90.05% | 2.96 57.16% | 3.74 26.49% | 13.35 256.98% | 0.16 98.82% | 2.63 1,573.43% | ||
free cash flow per share | -0.03 - | -0.02 9.62% | -10.04 40,604.44% | -11.71 16.57% | -11.49 1.88% | -3.95 65.61% | -2.07 47.60% | -0.90 56.44% | -0.71 21.05% | 7.27K 1,021,285.24% | |
free cash flow yield | -0.00 - | -0.00 9.62% | -0.07 89,449.78% | -0.19 184.31% | -1.06 458.76% | -0.93 12.61% | -1.12 20.39% | -0.36 67.77% | -1.90 426.31% | 18.17K 957,461.16% | |
graham net net | -0.02 - | -0.07 301.00% | -0.52 606.41% | -7.85 1,411.06% | -10.87 38.50% | -0.19 98.26% | -0.39 103.39% | -0.58 49.37% | 0.18 131.05% | -0.54 401.38% | |
graham number | 0.10 - | 0.30 200.54% | 5.20 1,621.32% | 74.06 1,324.46% | 122.32 65.16% | 34.14 72.09% | 19.40 43.18% | 6.26 67.73% | 5.49 12.35% | 103.53 1,787.07% | |
income quality | 1.11 - | 0.45 59.87% | -4.58 1,124.71% | 1.78 138.76% | 0.53 70.32% | 0.87 65.89% | 0.36 58.57% | 0.34 6.30% | 0.40 17.38% | 0.68 71.87% | |
intangibles to total assets | 0 - | 0 | 0 | 0.94 Infinity% | 0.95 0.14% | 0.87 7.78% | 0.68 22.32% | 0.60 11.58% | 0 100% | 0.04 Infinity% | |
interest coverage | -2.34K - | -181.87 92.22% | -2.24 98.77% | -2.23 0.31% | -15.19 - | -5.78 61.92% | -45.03 678.61% | ||||
interest debt per share | 0.01 - | 4.30 72,075.20% | 6.74 56.87% | 1.38 79.48% | 0.47 66.25% | 0.80 72.34% | 0.14 82.44% | 0.36 158.45% | |||
inventory turnover | 1.70 - | 1.70 0.43% | 4.02 136.95% | 0.84 79.02% | 0.39 53.80% | 0.27 30.93% | 0.79 192.93% | ||||
invested capital | 0.11 - | 0.00 97.74% | 0.16 - | 1.13 625.96% | -1.47 - | ||||||
market cap | 176.62M - | 176.62M 0% | 71.56M 59.48% | 37.63M 47.41% | 7.27M 80.68% | 10.04M 38.13% | 8.24M 17.92% | 12.82M 55.54% | 2.19M 82.91% | 2.76M 26.01% | |
net current asset value | -9.81K - | -39.34K 301.00% | 187.16K 575.76% | -4.38M 2,437.74% | -6.71M 53.41% | 479.41K 107.14% | 626.92K 30.77% | -2.07M 430.52% | 2.84M 236.87% | -2.23M 178.46% | |
net debt to ebitda | 0.34 - | 0.11 67.45% | 0.82 646.13% | -0.28 134.02% | 0.05 116.99% | 0.06 35.90% | 0.02 72.70% | -0.52 3,033.60% | 0.45 188.16% | -0.42 191.46% | |
net income per share | -0.02 - | -0.06 125.25% | 2.17 4,036.74% | -6.43 396.19% | -21.88 240.10% | -4.47 79.58% | -5.60 25.27% | -2.72 51.36% | -2.67 1.87% | -2.00K 74,958.76% | |
operating cash flow per share | -0.03 - | -0.02 9.62% | -9.95 40,240.26% | -11.43 14.81% | -11.45 0.24% | -3.91 65.89% | -2.03 47.94% | -0.90 55.68% | -0.71 21.29% | -0.49 30.86% | |
payables turnover | 0.42 - | 0.50 - | 0.56 12.16% | 1.42 155.37% | 1.04 26.54% | 0.59 43.12% | 1.05 77.17% | 1.46 39.21% | |||
receivables turnover | 1.34 - | 4.10 205.02% | 1.12 72.68% | 2.36 110.87% | 0.56 76.32% | 4.63 728.07% | 3.98 14.03% | ||||
research and ddevelopement to revenue | 4.66 - | 2.86 38.55% | 0.98 65.82% | 1.81 84.67% | 1.25 30.80% | 0.78 37.28% | 0.50 36.18% | ||||
return on tangible assets | -2.96 - | -9.11 207.23% | 0.17 101.82% | -2.42 1,553.67% | -9.38 288.45% | -2.68 71.45% | -4.17 55.68% | -3.96 5.07% | -3.34 15.66% | -4.29K 128,315.92% | |
revenue per share | 0.01 - | 0.01 15.38% | 0.93 - | 1.47 56.93% | 1.37 6.35% | 0.48 64.82% | 0.23 51.85% | 0.22 6.34% | 0.26 19.97% | ||
roe | 1.34 - | 0.75 43.83% | 3.93 423.06% | -0.17 104.32% | -0.72 324.03% | -0.39 46.49% | -1.87 386.15% | -4.25 127.21% | -5.33 25.34% | 8.44K 158,306.76% | |
roic | 1.34 - | 0.75 43.83% | -211.23 28,240.96% | 0.01 100.00% | -0.49 5,141.79% | -0.27 46.02% | -0.73 173.73% | -0.90 23.78% | -2.45 171.31% | -13.13K 536,918.42% | |
sales general and administrative to revenue | 3.52 - | 4.75 35.04% | 7.60 - | 5.19 31.72% | 1.61 68.90% | 2.78 72.03% | 3.83 37.86% | 2.20 42.45% | 1.62 26.34% | ||
shareholders equity per share | -0.02 - | -0.07 301.00% | 0.55 852.64% | 37.90 6,750.76% | 30.40 19.79% | 11.60 61.84% | 2.99 74.23% | 0.64 78.59% | 0.50 21.71% | -0.24 147.44% | |
stock based compensation to revenue | 1.48 - | 1.56 5.71% | 0.42 73.39% | 0.83 99.32% | 0.69 17.03% | 0.30 56.04% | 0.21 30.88% | ||||
tangible asset value | -9.81K - | -39.34K 301.00% | 263.91K 770.87% | -4.15M 1,671.70% | -6.55M 57.96% | 671.94K 110.26% | 781.07K 16.24% | -1.98M 353.31% | 2.93M 247.95% | -1.77M 160.61% | |
tangible book value per share | -0.02 - | -0.07 301.00% | 0.55 852.64% | -6.78 1,325.28% | -9.73 43.59% | 0.28 102.92% | 0.18 38.35% | -0.39 320.08% | 0.50 229.83% | -0.26 151.31% | |
working capital | -9.81K - | -39.34K 301.00% | 187.16K 575.76% | -4.38M 2,437.74% | -6.71M 53.41% | 479.41K 107.14% | 626.92K 30.77% | -662.19K 205.63% | 3.09M 567.03% | 468.38K 84.86% |
All numbers in USD (except ratios and percentages)